GalacticBounty
@mmnlnsinfant
A 2025 study from Washington University highlights a doubled risk of pancreatitis, an 11% rise in arthritis risk, and increased chances of low blood pressure and serious kidney disease for 215,000 users of injectable obesity drugs like Ozempic, Wegovy, and Mounjaro.
0 reply
0 recast
0 reaction